Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (31-40 of 528) with videos related to

Pageof 53
Sort By:
Journal of the American Academy of Dermatology|February 1, 1986
Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanomaR F Wagner, L Nathanson
Cancer Genetics|March 21, 2012
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundLauren Fishbein, Katherine L Nathanson
Seminars in Oncology|June 1, 1997
Introduction: paraneoplastic syndromesL Nathanson, T C Hall
JAMA Oncology|April 7, 2017
Pheochromocytoma and Paraganglioma Susceptibility Genes: Estimating the Associated Risk of DiseaseLauren Fishbein, Katherine L Nathanson
National Cancer Institute Monograph|December 1, 1973
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary reportL Nathanson, D A Clark
Progress in Clinical and Biological Research|January 1, 1987
Mitoxantrone salvage in heavily pretreated advanced breast cancerL Nathanson, M E Williams
Progress in Clinical Immunology|January 1, 1974
Carcinofetal antigensM E Costanza, L Nathanson
The Journal of Biological Chemistry|August 10, 2000
Active aminoacyl-tRNA synthetases are present in nuclei as a high molecular weight multienzyme complexL Nathanson, M P Deutscher
Cancer Treatment and Research|January 1, 1993
Positive and negative growth regulation in melanoma: growth factors, intracellular signalling, and the cell cycleD L Coppock, L Nathanson
Nutrition and Cancer|January 1, 1983
High-dose pyridoxal supplemented culture medium inhibits the growth of a human malignant melanoma cell lineD M DiSorbo, L Nathanson
Pageof 53

Showing results (31-40 of 528) with videos related to

Sort By:
Pageof 53
Journal of the American Academy of Dermatology|February 1, 1986
Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanomaR F Wagner, L Nathanson
Cancer Genetics|March 21, 2012
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundLauren Fishbein, Katherine L Nathanson
Seminars in Oncology|June 1, 1997
Introduction: paraneoplastic syndromesL Nathanson, T C Hall
JAMA Oncology|April 7, 2017
Pheochromocytoma and Paraganglioma Susceptibility Genes: Estimating the Associated Risk of DiseaseLauren Fishbein, Katherine L Nathanson
National Cancer Institute Monograph|December 1, 1973
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary reportL Nathanson, D A Clark
Progress in Clinical and Biological Research|January 1, 1987
Mitoxantrone salvage in heavily pretreated advanced breast cancerL Nathanson, M E Williams
Progress in Clinical Immunology|January 1, 1974
Carcinofetal antigensM E Costanza, L Nathanson
The Journal of Biological Chemistry|August 10, 2000
Active aminoacyl-tRNA synthetases are present in nuclei as a high molecular weight multienzyme complexL Nathanson, M P Deutscher
Cancer Treatment and Research|January 1, 1993
Positive and negative growth regulation in melanoma: growth factors, intracellular signalling, and the cell cycleD L Coppock, L Nathanson
Nutrition and Cancer|January 1, 1983
High-dose pyridoxal supplemented culture medium inhibits the growth of a human malignant melanoma cell lineD M DiSorbo, L Nathanson
Pageof 53